INVEGA® Approved as Treatment for Schizophrenia in A... (gely in patients taking atypical antipsy...)

INVEGA® Approved as Treatment for Schizophrenia in Adolescents

Date:4/11/2011

gely in patients taking atypical antipsychotic drugs, revealed a risk of death in the drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. INVEGA® is not approved for the treatment of patients with dementia-related psychosis.

Contraindications: Paliperidone is contraindicated in patients with a known hypersensitivity to either paliperidone, risperidone, or to any of the components in the formulation.

Cerebrovascular Adverse Events (CAEs): CAEs (e.g., stroke, transient ischemia attacks), including fatalities, were reported in placebo-controlled trials in elderly patients with dementia-related psychosis taking oral risperidone, aripiprazole, and olanzapine. The incidence of CAEs was significantly higher than with placebo. INVEGA® is not approved for the treatment of patients with dementia-related psychosis.

Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported with the use of antipsychotic medications, including paliperidone. Clinical manifestations include muscle rigidity, fever, altered mental status, and evidence of autonomic instability (see full Prescribing Information). Management should include immediate discontinuation of antipsychotic drugs and other drugs not essenti
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®
2. FDA CONSUMER HEALTH INFORMATION - FDA Intends to Remove Unapproved Drugs From Market
3. FDA Prompts Removal of Unapproved Drugs From Market
4. Roche Teams with Womack Army Medical Center to Become First IVD Manufacturer approved for Remote Network Connectivity with DOD
5. DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product
6. FDA: Gardasil Approved to Prevent Anal Cancer
7. CO-REC Unveils List of Approved Electronic Health Record Products
8. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
9. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
10. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
11. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 More than half of ... benefit from chemotherapy and still have excellent outcomes. To ... one of the largest sources of online consumer information ... interactive Facebook page provide recently diagnosed women with information ... avoid chemotherapy. "We anticipate these innovative social ...

(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...

(Date:5/23/2013)... -- Ameritox, the nation,s leader in pain medication monitoring, ... become part of its Urine Drug Monitoring (UDM) ... improve the clinical outcomes for injured workers. ... in the workers, compensation industry, has used UDM ... strategy for several years. By establishing a comprehensive ...

Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3 TMA Launches Physician Services Organization for Patient Care 2 TMA Launches Physician Services Organization for Patient Care 3 TMA Launches Physician Services Organization for Patient Care 4 Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2 Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3

[0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions [0] TMA Launches Physician Services Organization for Patient Care [0] Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers

... OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ... announced that it will be hosting the autumn eClinical ... in Fort Lauderdale, Florida from November 03-05, 2010. The ... Life Science organizations. The informal ambiance provides support for ...

... Calif., Sept. 21 Bionovo, Inc. (Nasdaq: BNVI, BNVID), a ... in women,s health and oncology, today announced that Dr. Isaac ... at the JMP Securities Healthcare Conference at 4:00 p.m. ET ... at the New York Palace hotel in New York City. ...

Cached Medicine Technology:OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 2 OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 3 Bionovo to Present at the JMP Securities Healthcare Conference 2

OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting Bionovo to Present at the JMP Securities Healthcare Conference

(Date:5/24/2013)... HealthDay Reporter , , FRIDAY, May 24 (HealthDay ... are remarkable. But it was a physical challenge in ... of her sport. "I was an 11-year-old girl ... scoliosis was diagnosed by my orthopedic surgeon," said Lewis, ... Research Society and the American Academy of Orthopaedic Surgeons ...

(Date:5/24/2013)... 24, 2013 ResortQuest Real Estate® is ... Dayna Feher team at the firm’s Bethany Beach location. ... resorts her home in 1975. Her real estate career ... all aspects of the real estate business - receptionist, ... 12 years, a licensed sales associate. , “I ...

(Date:5/24/2013)... 24, 2013 The Mirena IUD lawyers ... news that the FDA has received more than 59,229 complaints ... from the intrauterine birth control device known as the Mirena ... issues reported by the women “included ‘expulsion,’ where the IUD ... that occurring,” according to an ABC News article. “Abdominal pain ...

(Date:5/24/2013)... CHI-California Healthcare Institute today submitted ... congressional delegation, joined by over 40 biomedical companies, ... paid to the U.S. Food and Drug Administration ... cuts will not include user fees paid to ... Development and FDA Appropriations Bill. CHI is a ...

(Date:5/24/2013)... Started in 1982, AMTC’s SHINE event is ... marks AMTC’s 31st anniversary. SHINE is a ministry run by ... Lewis and her daughter, Carey Lewis Arban. , This summer’s ... and music professionals including the New York Film Academy, The ... are kings of Hollywood and Christian casting directors. They seek ...

Breaking Medicine News(10 mins):Health News:Top-Ranked Golfer Beats Scoliosis 2 Health News:Top-Ranked Golfer Beats Scoliosis 3 Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2 Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3 Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2

[0] Top-Ranked Golfer Beats Scoliosis [0] Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team [0] Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes [0] California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 [0] AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013

... some states have cut breast cancer screening programs , TUESDAY, ... mammograms for women ages 40 to 49 has decreased since ... the U.S. Preventive Services Task Force, according to a new ... risk for breast cancer should start having mammograms every two ...

... at the Mayo Clinic campus in Florida have found ... lung cancers, is over-produced in pancreatic cancer and is ... genetically inhibiting PKC in laboratory animals led to a ... The discovery, reported in the March 1 issue of ...

... ... ... ... ...

... often think about hot flashes, hormone shifts and mood swings. ... of heart disease intensifies drastically around the time of natural menopause, ... This news may come as a surprise, but experts explain that ... that there are ways to lower your risk. ...

... ... at the Parallels Summit 2010 , ... Miami, FL (PRWEB) February 23, 2010 -- Worldwide cloud enablement leader, ... Parallels Summit 2010., , ,Highlighting excellence in the industry, the awards recognize the outstanding ...

... ... ... ... ...

Access to Mammograms Drops After Guidelines Change Mayo Clinic researchers find oncogene is important in pancreatic cancer growth and spread Monique da Silva Joins Ogilvy Public Relations Worldwide to Lead North America Healthcare Practice Changes during menopause increases risk of heart disease and stroke Winners are Grinners at the Inaugural Parallels Partner Awards Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease

Rhoton Curettes, titanium, length 191 mm, straight....

Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....

Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....

Medicine Products:

Rhoton Curettes Micro Needle Holder Vascular Clamps ABB-11 Vascular Clamps B-1